APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Combination Vaccine and Multivalent Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Veterinary Combination Vaccine and Multivalent Vaccine Market Analysis and Forecast 2026-2032

27 December 2025205 pages

Choose your research edition.

Industry ResearchVeterinary Combination Vaccine and Multivalent Vaccine Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Combination Vaccine and Multivalent Vaccine Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Veterinary Combination Vaccine and Multivalent Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Combination Vaccine and Multivalent Vaccine Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Combination Vaccine and Multivalent Vaccine Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Veterinary Combination Vaccine and Multivalent Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Veterinary Combination Vaccine and Multivalent Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Veterinary Combination Vaccine and Multivalent Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Veterinary Combination Vaccine and Multivalent Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Veterinary Combination Vaccine and Multivalent Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Veterinary Combination Vaccine and Multivalent Vaccine include Bioveta, Boehringer Ingelheim, Ceva Animal Health, Elanco, HIPRA, Merck Animal Health, Virbac, Zoetis and Aichong Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Veterinary Combination Vaccine and Multivalent Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Veterinary Combination Vaccine and Multivalent Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Combination Vaccine and Multivalent Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Combination Vaccine and Multivalent Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Combination Vaccine and Multivalent Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Combination Vaccine and Multivalent Vaccine sales, projected growth trends, production technology, application and end-user industry.

Veterinary Combination Vaccine and Multivalent Vaccine Segment by Company

Bioveta

Boehringer Ingelheim

Ceva Animal Health

Elanco

HIPRA

Merck Animal Health

Virbac

Zoetis

Aichong Group

Bolaideli Biotechnology

Harbin Pharmaceutical Group

Huapai Biotechnology

Keqian Biology

Pulike Biological

Ringpu Bio-technology

Yian Biological

China Animal Husbandy Industry

Veterinary Combination Vaccine and Multivalent Vaccine Segment by Type

Combination Vaccine

Multivalent Vaccine

Veterinary Combination Vaccine and Multivalent Vaccine Segment by Application

Domestic Animal

Poultry

Veterinary Combination Vaccine and Multivalent Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Combination Vaccine and Multivalent Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Combination Vaccine and Multivalent Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Combination Vaccine and Multivalent Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Veterinary Combination Vaccine and Multivalent Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Veterinary Combination Vaccine and Multivalent Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Combination Vaccine and Multivalent Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Combination Vaccine and Multivalent Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Combination Vaccine Major Manufacturers Table 3. Multivalent Vaccine Major Manufacturers Table 4. Global Veterinary Combination Vaccine and Multivalent Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Domestic Animal Major Manufacturers Table 6. Poultry Major Manufacturers Table 7. Veterinary Combination Vaccine and Multivalent Vaccine Industry Trends Table 8. Veterinary Combination Vaccine and Multivalent Vaccine Industry Drivers Table 9. Veterinary Combination Vaccine and Multivalent Vaccine Industry Opportunities and Challenges Table 10. Veterinary Combination Vaccine and Multivalent Vaccine Industry Restraints Table 11. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 17. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region (2021-2026) & (Units) Table 18. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region (2027-2032) & (Units) Table 19. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Veterinary Combination Vaccine and Multivalent Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Veterinary Combination Vaccine and Multivalent Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Veterinary Combination Vaccine and Multivalent Vaccine Manufacturers, Product Type & Application Table 29. Global Veterinary Combination Vaccine and Multivalent Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Veterinary Combination Vaccine and Multivalent Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type 2021 VS 2025 VS 2032 (Units) Table 38. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021-2026) & (Units) Table 39. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2027-2032) & (Units) Table 40. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Veterinary Combination Vaccine and Multivalent Vaccine Price by Type (2021-2026) & (US$/Unit) Table 43. Global Veterinary Combination Vaccine and Multivalent Vaccine Price by Type (2027-2032) & (US$/Unit) Table 44. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application 2021 VS 2025 VS 2032 (Units) Table 50. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021-2026) & (Units) Table 51. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2027-2032) & (Units) Table 52. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Veterinary Combination Vaccine and Multivalent Vaccine Price by Application (2021-2026) & (US$/Unit) Table 55. Global Veterinary Combination Vaccine and Multivalent Vaccine Price by Application (2027-2032) & (US$/Unit) Table 56. Bioveta Company Information Table 57. Bioveta Business Overview Table 58. Bioveta Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Bioveta Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 60. Bioveta Recent Development Table 61. Boehringer Ingelheim Company Information Table 62. Boehringer Ingelheim Business Overview Table 63. Boehringer Ingelheim Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Boehringer Ingelheim Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 65. Boehringer Ingelheim Recent Development Table 66. Ceva Animal Health Company Information Table 67. Ceva Animal Health Business Overview Table 68. Ceva Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Ceva Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 70. Ceva Animal Health Recent Development Table 71. Elanco Company Information Table 72. Elanco Business Overview Table 73. Elanco Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Elanco Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 75. Elanco Recent Development Table 76. HIPRA Company Information Table 77. HIPRA Business Overview Table 78. HIPRA Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. HIPRA Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 80. HIPRA Recent Development Table 81. Merck Animal Health Company Information Table 82. Merck Animal Health Business Overview Table 83. Merck Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merck Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 85. Merck Animal Health Recent Development Table 86. Virbac Company Information Table 87. Virbac Business Overview Table 88. Virbac Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Virbac Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 90. Virbac Recent Development Table 91. Zoetis Company Information Table 92. Zoetis Business Overview Table 93. Zoetis Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Zoetis Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 95. Zoetis Recent Development Table 96. Aichong Group Company Information Table 97. Aichong Group Business Overview Table 98. Aichong Group Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Aichong Group Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 100. Aichong Group Recent Development Table 101. Bolaideli Biotechnology Company Information Table 102. Bolaideli Biotechnology Business Overview Table 103. Bolaideli Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Bolaideli Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 105. Bolaideli Biotechnology Recent Development Table 106. Harbin Pharmaceutical Group Company Information Table 107. Harbin Pharmaceutical Group Business Overview Table 108. Harbin Pharmaceutical Group Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Harbin Pharmaceutical Group Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 110. Harbin Pharmaceutical Group Recent Development Table 111. Huapai Biotechnology Company Information Table 112. Huapai Biotechnology Business Overview Table 113. Huapai Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Huapai Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 115. Huapai Biotechnology Recent Development Table 116. Keqian Biology Company Information Table 117. Keqian Biology Business Overview Table 118. Keqian Biology Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Keqian Biology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 120. Keqian Biology Recent Development Table 121. Pulike Biological Company Information Table 122. Pulike Biological Business Overview Table 123. Pulike Biological Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Pulike Biological Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 125. Pulike Biological Recent Development Table 126. Ringpu Bio-technology Company Information Table 127. Ringpu Bio-technology Business Overview Table 128. Ringpu Bio-technology Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Ringpu Bio-technology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 130. Ringpu Bio-technology Recent Development Table 131. Yian Biological Company Information Table 132. Yian Biological Business Overview Table 133. Yian Biological Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Yian Biological Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 135. Yian Biological Recent Development Table 136. China Animal Husbandy Industry Company Information Table 137. China Animal Husbandy Industry Business Overview Table 138. China Animal Husbandy Industry Veterinary Combination Vaccine and Multivalent Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. China Animal Husbandy Industry Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio Table 140. China Animal Husbandy Industry Recent Development Table 141. North America Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 142. North America Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 143. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021-2026) & (Units) Table 144. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2027-2032) & (Units) Table 145. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 146. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 147. North America Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 148. North America Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 149. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021-2026) & (Units) Table 150. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2027-2032) & (Units) Table 151. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 152. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 153. North America Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. North America Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. North America Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 157. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021-2026) & (Units) Table 158. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2027-2032) & (Units) Table 159. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 160. North America Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 161. United States Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 162. Canada Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 163. Mexico Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 164. Europe Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 165. Europe Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 166. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021-2026) & (Units) Table 167. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2027-2032) & (Units) Table 168. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 169. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 170. Europe Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 171. Europe Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 172. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021-2026) & (Units) Table 173. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2027-2032) & (Units) Table 174. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 175. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Europe Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Europe Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Europe Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 180. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021-2026) & (Units) Table 181. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2027-2032) & (Units) Table 182. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 183. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Germany Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 185. France Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 186. U.K. Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 187. Italy Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 188. Russia Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Spain Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 190. Netherlands Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Switzerland Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 192. Sweden Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 193. Poland Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 194. China Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 195. China Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 196. China Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021-2026) & (Units) Table 197. China Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2027-2032) & (Units) Table 198. China Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 199. China Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 200. China Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 201. China Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 202. China Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021-2026) & (Units) Table 203. China Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2027-2032) & (Units) Table 204. China Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 205. China Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Asia Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 207. Asia Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 208. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021-2026) & (Units) Table 209. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2027-2032) & (Units) Table 210. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 211. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 212. Asia Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 213. Asia Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 214. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021-2026) & (Units) Table 215. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2027-2032) & (Units) Table 216. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 217. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 218. Asia Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. Asia Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. Asia Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 222. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021-2026) & (Units) Table 223. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2027-2032) & (Units) Table 224. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 225. Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 226. Japan Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 227. South Korea Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 228. India Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 229. Australia Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 230. Taiwan Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 231. Southeast Asia Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 232. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 233. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 234. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021-2026) & (Units) Table 235. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2027-2032) & (Units) Table 236. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 237. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 238. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 239. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 240. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021-2026) & (Units) Table 241. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2027-2032) & (Units) Table 242. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 243. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 244. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 248. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021-2026) & (Units) Table 249. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2027-2032) & (Units) Table 250. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 251. SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 252. Brazil Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 253. Argentina Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 254. Chile Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 255. Colombia Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 256. Peru Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 257. Saudi Arabia Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 258. Israel Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 259. UAE Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 260. Turkey Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 261. Iran Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 262. Egypt Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Table 263. Key Raw Materials Table 264. Raw Materials Key Suppliers Table 265. Veterinary Combination Vaccine and Multivalent Vaccine Distributors List Table 266. Veterinary Combination Vaccine and Multivalent Vaccine Customers List Table 267. Research Programs/Design for This Report Table 268. Authors List of This Report Table 269. Secondary Sources Table 270. Primary Sources List of Figures Figure 1. Veterinary Combination Vaccine and Multivalent Vaccine Image Figure 2. Global Veterinary Combination Vaccine and Multivalent Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Combination Vaccine and Multivalent Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Combination Vaccine Image Figure 5. Multivalent Vaccine Image Figure 6. Global Veterinary Combination Vaccine and Multivalent Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Veterinary Combination Vaccine and Multivalent Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Domestic Animal Image Figure 9. Poultry Image Figure 10. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales (2021-2032) & (Units) Figure 16. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 17. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Veterinary Combination Vaccine and Multivalent Vaccine Sales YoY (2021-2032) & (Units) Figure 19. Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales YoY (2021-2032) & (Units) Figure 20. China Veterinary Combination Vaccine and Multivalent Vaccine Sales YoY (2021-2032) & (Units) Figure 21. Asia (Excluding China) Veterinary Combination Vaccine and Multivalent Vaccine Sales YoY (2021-2032) & (Units) Figure 22. South America, Middle East and Africa Veterinary Combination Vaccine and Multivalent Vaccine Sales YoY (2021-2032) & (Units) Figure 23. Global Veterinary Combination Vaccine and Multivalent Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Veterinary Combination Vaccine and Multivalent Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 30. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Veterinar

Scope & coverage.

Types
  • Combination Vaccine
  • Multivalent Vaccine
Applications
  • Domestic Animal
  • Poultry
Companies covered
  • Bioveta
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Elanco
  • HIPRA
  • Merck Animal Health
  • Virbac
  • Zoetis
  • Aichong Group
  • Bolaideli Biotechnology
  • Harbin Pharmaceutical Group
  • Huapai Biotechnology
  • Keqian Biology
  • Pulike Biological
  • Ringpu Bio-technology
  • Yian Biological
  • China Animal Husbandy Industry

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Veterinary Combination Vaccine and Multivalent Vaccine Market by Type
  3. 1.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Combination Vaccine
  5. 1.2.3 Multivalent Vaccine
  6. 1.3 Veterinary Combination Vaccine and Multivalent Vaccine Market by Application
  7. 1.3.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Domestic Animal
  9. 1.3.3 Poultry
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Veterinary Combination Vaccine and Multivalent Vaccine Market Dynamics
  1. 2.1 Veterinary Combination Vaccine and Multivalent Vaccine Industry Trends
  2. 2.2 Veterinary Combination Vaccine and Multivalent Vaccine Industry Drivers
  3. 2.3 Veterinary Combination Vaccine and Multivalent Vaccine Industry Opportunities and Challenges
  4. 2.4 Veterinary Combination Vaccine and Multivalent Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Region
  3. 3.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region
  9. 3.4.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Manufacturers
  6. 4.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Veterinary Combination Vaccine and Multivalent Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Veterinary Combination Vaccine and Multivalent Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Veterinary Combination Vaccine and Multivalent Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Veterinary Combination Vaccine and Multivalent Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Veterinary Combination Vaccine and Multivalent Vaccine Tier 1, Tier 2, and Tier 3
5 Veterinary Combination Vaccine and Multivalent Vaccine Market by Type
  1. 5.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type
  2. 5.1.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type
  6. 5.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Price by Type
6 Veterinary Combination Vaccine and Multivalent Vaccine Market by Application
  1. 6.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application
  2. 6.1.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application
  6. 6.2.1 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Veterinary Combination Vaccine and Multivalent Vaccine Price by Application
7 Company Profiles
  1. 7.1 Bioveta
  2. 7.1.1 Bioveta Company Information
  3. 7.1.2 Bioveta Business Overview
  4. 7.1.3 Bioveta Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bioveta Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  6. 7.1.5 Bioveta Recent Developments
  7. 7.2 Boehringer Ingelheim
  8. 7.2.1 Boehringer Ingelheim Company Information
  9. 7.2.2 Boehringer Ingelheim Business Overview
  10. 7.2.3 Boehringer Ingelheim Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Boehringer Ingelheim Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  12. 7.2.5 Boehringer Ingelheim Recent Developments
  13. 7.3 Ceva Animal Health
  14. 7.3.1 Ceva Animal Health Company Information
  15. 7.3.2 Ceva Animal Health Business Overview
  16. 7.3.3 Ceva Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ceva Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  18. 7.3.5 Ceva Animal Health Recent Developments
  19. 7.4 Elanco
  20. 7.4.1 Elanco Company Information
  21. 7.4.2 Elanco Business Overview
  22. 7.4.3 Elanco Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Elanco Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  24. 7.4.5 Elanco Recent Developments
  25. 7.5 HIPRA
  26. 7.5.1 HIPRA Company Information
  27. 7.5.2 HIPRA Business Overview
  28. 7.5.3 HIPRA Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 HIPRA Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  30. 7.5.5 HIPRA Recent Developments
  31. 7.6 Merck Animal Health
  32. 7.6.1 Merck Animal Health Company Information
  33. 7.6.2 Merck Animal Health Business Overview
  34. 7.6.3 Merck Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Merck Animal Health Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  36. 7.6.5 Merck Animal Health Recent Developments
  37. 7.7 Virbac
  38. 7.7.1 Virbac Company Information
  39. 7.7.2 Virbac Business Overview
  40. 7.7.3 Virbac Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Virbac Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  42. 7.7.5 Virbac Recent Developments
  43. 7.8 Zoetis
  44. 7.8.1 Zoetis Company Information
  45. 7.8.2 Zoetis Business Overview
  46. 7.8.3 Zoetis Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Zoetis Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  48. 7.8.5 Zoetis Recent Developments
  49. 7.9 Aichong Group
  50. 7.9.1 Aichong Group Company Information
  51. 7.9.2 Aichong Group Business Overview
  52. 7.9.3 Aichong Group Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Aichong Group Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  54. 7.9.5 Aichong Group Recent Developments
  55. 7.10 Bolaideli Biotechnology
  56. 7.10.1 Bolaideli Biotechnology Company Information
  57. 7.10.2 Bolaideli Biotechnology Business Overview
  58. 7.10.3 Bolaideli Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Bolaideli Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  60. 7.10.5 Bolaideli Biotechnology Recent Developments
  61. 7.11 Harbin Pharmaceutical Group
  62. 7.11.1 Harbin Pharmaceutical Group Company Information
  63. 7.11.2 Harbin Pharmaceutical Group Business Overview
  64. 7.11.3 Harbin Pharmaceutical Group Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Harbin Pharmaceutical Group Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  66. 7.11.5 Harbin Pharmaceutical Group Recent Developments
  67. 7.12 Huapai Biotechnology
  68. 7.12.1 Huapai Biotechnology Company Information
  69. 7.12.2 Huapai Biotechnology Business Overview
  70. 7.12.3 Huapai Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Huapai Biotechnology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  72. 7.12.5 Huapai Biotechnology Recent Developments
  73. 7.13 Keqian Biology
  74. 7.13.1 Keqian Biology Company Information
  75. 7.13.2 Keqian Biology Business Overview
  76. 7.13.3 Keqian Biology Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Keqian Biology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  78. 7.13.5 Keqian Biology Recent Developments
  79. 7.14 Pulike Biological
  80. 7.14.1 Pulike Biological Company Information
  81. 7.14.2 Pulike Biological Business Overview
  82. 7.14.3 Pulike Biological Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Pulike Biological Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  84. 7.14.5 Pulike Biological Recent Developments
  85. 7.15 Ringpu Bio-technology
  86. 7.15.1 Ringpu Bio-technology Company Information
  87. 7.15.2 Ringpu Bio-technology Business Overview
  88. 7.15.3 Ringpu Bio-technology Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Ringpu Bio-technology Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  90. 7.15.5 Ringpu Bio-technology Recent Developments
  91. 7.16 Yian Biological
  92. 7.16.1 Yian Biological Company Information
  93. 7.16.2 Yian Biological Business Overview
  94. 7.16.3 Yian Biological Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Yian Biological Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  96. 7.16.5 Yian Biological Recent Developments
  97. 7.17 China Animal Husbandy Industry
  98. 7.17.1 China Animal Husbandy Industry Company Information
  99. 7.17.2 China Animal Husbandy Industry Business Overview
  100. 7.17.3 China Animal Husbandy Industry Veterinary Combination Vaccine and Multivalent Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 China Animal Husbandy Industry Veterinary Combination Vaccine and Multivalent Vaccine Product Portfolio
  102. 7.17.5 China Animal Husbandy Industry Recent Developments
8 North America
  1. 8.1 North America Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Type
  2. 8.1.1 North America Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Veterinary Combination Vaccine and Multivalent Vaccine Price by Type (2021-2032)
  5. 8.2 North America Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Application
  6. 8.2.1 North America Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Veterinary Combination Vaccine and Multivalent Vaccine Price by Application (2021-2032)
  9. 8.3 North America Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country
  10. 8.3.1 North America Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Veterinary Combination Vaccine and Multivalent Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Type
  2. 9.1.1 Europe Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Veterinary Combination Vaccine and Multivalent Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Application
  6. 9.2.1 Europe Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Veterinary Combination Vaccine and Multivalent Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country
  10. 9.3.1 Europe Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Veterinary Combination Vaccine and Multivalent Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Type
  2. 10.1.1 China Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Veterinary Combination Vaccine and Multivalent Vaccine Price by Type (2021-2032)
  5. 10.2 China Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Application
  6. 10.2.1 China Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Veterinary Combination Vaccine and Multivalent Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Type
  2. 11.1.1 Asia Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Veterinary Combination Vaccine and Multivalent Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Application
  6. 11.2.1 Asia Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Veterinary Combination Vaccine and Multivalent Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country
  10. 11.3.1 Asia Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Veterinary Combination Vaccine and Multivalent Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Type
  2. 12.1.1 SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Application
  6. 12.2.1 SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Market Size by Country
  10. 12.3.1 SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Veterinary Combination Vaccine and Multivalent Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Veterinary Combination Vaccine and Multivalent Vaccine Value Chain Analysis
  2. 13.1.1 Veterinary Combination Vaccine and Multivalent Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Veterinary Combination Vaccine and Multivalent Vaccine Production Mode & Process
  6. 13.2 Veterinary Combination Vaccine and Multivalent Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Veterinary Combination Vaccine and Multivalent Vaccine Distributors
  9. 13.2.3 Veterinary Combination Vaccine and Multivalent Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst